In Vitro ADME / DMPK CROs
44 published
44 published CROs match In Vitro ADME / DMPK.
Locations in this set include United States, Canada, China, India, United Kingdom, and France.
Capabilities that show up most often in this set: Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, and Gene Therapy.
Matching companies
TRiCBIOTRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
VitroGenLabs Hungary Kft.GLP-accredited in vitro CRO specializing in OECD-validated skin corrosion, skin irritation, and ocular irritation testing using reconstructed human tissue models. Serves pharmaceutical, cosmetic, chemical, and medical device companies with non-animal alternatives for REACH, CLP, cosmetics, and FDA submissions.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /services/in-vitro-admet.md